Home
About Us
Profile
Message from Chairman
Board of Directors
Directors / Management
Committees of Board
Terms & Conditions
Payments Criteria to Non Executive Directors
Group Companies
Milestones
Contact Us
R & D
Products
Investor Relations
Disclosures under Regulation 46 of the LODR
Policies and Code
Annual Secretarial Compliance Reports
Investor Contacts
Shareholding Pattern
Investor Meet
Notifications
Recordings
Transcripts
Board Meetings
Intimation
Outcome
Newspaper Publications
Annual General Meetings
Notice
E Voting Result
Newspaper Publication
Postal Ballot
Notice
E Voting Result
Newspaper Publication
Corporate Social Responsibility Approved Projects
Presentations
SMART ODR
Reports
Unclaimed Dividends
Stock Price
KYC Forms
Article of Associations
News
Schemes
Home
»
About Us
»
Milestones
2011
Started manufacture of Rifamycin S an intermediate for Rifampicin, currently plant is running at full capacity with this product.
2003
Started manufacture of Lovastatin.
1992
GTBL developed 3 Formyl Rifamycin SV (3FRSV) and Rifampicin IP.
1991
Entered into a Joint venture agreement with Yuhan Corporation of South Korea to manufacture Rifampicin.
1981
Establishment of Gujarat Themis Biosyn Ltd in Fermentation business for manufacture of Erythromycin.